Mulligan Therapy Effects In Healthy Subjects With Induced Vertigo

Mulligan Therapy Effects In Healthy Subjects With Induced Vertigo. A Randomized And Controlled Clinic Study

This analysis aims to evaluate the immediate effect that cervical sustained natural apophyseal glides (SNAGs) have on a group of individuals with induced vertigo by a caloric vestibular stimulation.

Study Overview

• Status: Completed
• Conditions: Vertigo
• Intervention / Treatment: Procedure: sustained natural apophyseal glides; Procedure: SHAM SNAG

• Study Type: Interventional
• Enrollment (Actual): 30
• Phase: Not Applicable

Contacts and Locations

Study Locations

• Spain
  • Madrid, Spain, 28023
    • CSEU La Salle
  • Madrid, Spain, 28023
    • Jose V Leon Hernandez

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years to 44 years (Adult)
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: All

Description

Inclusion Criteria:

• Healthy subjects,
• Age 18-44 years.

Exclusion Criteria:

• Consume of antipsychotics, antidepressants, antiarrythmics and/or anticonvulsivants
• Hippoacusia
• Auditory diseases
• Peripheral or central vestibulopathies
• Cerviogenic dizziness
• Balance disorders
• Nistagmus
• Oculomotor nerve dysfunctions
• Migraine
• Cervical osteoporosis, lashing or fracture
• Discal cervical hernia
• Cervical neuropathy
• Psychriatic disorders
• Epilepsy
• Pregnancy

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Health Services Research
• Allocation: Randomized
• Interventional Model: Parallel Assignment
• Masking: Single

Number of Arms

3

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Experimental: SNAG GROUP; The SNAG group received a treatment based on sustained apophyseal glides in a postero-anterior direction on C2 with a dose of three series of ten repetitions each, combined with active cervical extension.	Procedure: sustained natural apophyseal glides; It consists on a sustained apophyseal glides in a postero-anterior direction on C2 with a dose of three series of ten repetitions each; Other Names: SNAG
Sham Comparator: SHAM SNAG GROUP; The placebo SNAG group received a simulation of the contact used for the SNAGs, without any vertebral glide, and with an active cervical extension.	Procedure: SHAM SNAG; Subjects on SNAG group received a simulation of the contact used for the SNAGs, without any vertebral glide, and with an active cervical extension
No Intervention: CONTROL GROUP; The control group did not receive any type of intervention, they only waited for four minutes, sat down on a chair

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
vHIT (Video Head Impulse Test)	Detection of peripheral vestibular deficits and their recovery	15 minutes

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Anxiety	state-trait anxiety was measured at the beginning of the study using the Spanish version of the trait-state anxiety inventory (STAI)	5 minutes

Collaborators and Investigators

• Sponsor: Centro Universitario La Salle

Study record dates

Study Major Dates

• Study Start (Actual): February 3, 2018
• Primary Completion (Actual): June 4, 2018
• Study Completion (Actual): June 28, 2018

Study Registration Dates

• First Submitted: October 19, 2021
• First Submitted That Met QC Criteria: November 3, 2021
• First Posted (Actual): November 12, 2021

Study Record Updates

• Last Update Posted (Actual): November 12, 2021
• Last Update Submitted That Met QC Criteria: November 3, 2021
• Last Verified: November 1, 2021

More Information

Terms related to this study

• Additional Relevant MeSH Terms: Nervous System Diseases; Neurologic Manifestations; Otorhinolaryngologic Diseases; Labyrinth Diseases; Ear Diseases; Vestibular Diseases; Sensation Disorders; Vertigo; Dizziness
• Other Study ID Numbers: CSEULS-PI-198/2018

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: No
• IPD Plan Description: Data will only be treated by study researchers

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No